Mac Etosh's questions to West Pharmaceutical Services Inc (WST) leadership • Q1 2025
Question
Mac Etosh asked how the year was progressing against internal expectations and inquired about the nature of recent restructuring charges, including whether they would recur.
Answer
CEO Eric Green responded that the year is progressing as planned, with the exception of a near-term HVP component issue related to pricing and a plant-specific constraint. CFO Bernard Birkett confirmed that restructuring costs, which related to minor site consolidations, are not expected to recur and the associated savings are already embedded in the guidance.